State of Wisconsin Investment Board
MRNA icon

State of Wisconsin Investment Board’s Moderna MRNA Stock Holding History

State of Wisconsin Investment Board’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Sell
207,705
-19,457
-9% -$1.01M 0.03% 497
2026
Q1 		$11.5M Sell
227,162
-780
-0.3% -$36.4K 0.03% 590
2025
Q4 		$6.72M Buy
227,942
+1,698
+0.8% +$46.1K 0.02% 878
2025
Q3 		$5.84M Buy
226,244
+99
+0% +$2.76K 0.01% 895
2025
Q2 		$6.24M Buy
226,145
+37,285
+20% +$982K 0.02% 854
2025
Q1 		$5.35M Buy
188,860
+4,934
+3% +$175K 0.01% 898
2024
Q4 		$7.65M Sell
183,926
-26,038
-12% -$1.24M 0.02% 778
2024
Q3 		$14M Buy
209,964
+809
+0.4% +$74.3K 0.04% 492
2024
Q2 		$24.8M Buy
209,155
+11,029
+6% +$1.4M 0.07% 269
2024
Q1 		$21.1M Buy
198,126
+2,480
+1% +$250K 0.06% 319
2023
Q4 		$19.5M Buy
195,646
+23,237
+13% +$1.95M 0.06% 330
2023
Q3 		$17.8M Buy
172,409
+1,692
+1% +$189K 0.06% 340
2023
Q2 		$20.7M Sell
170,717
-35,179
-17% -$4.69M 0.06% 328
2023
Q1 		$31.6M Buy
205,896
+19,925
+11% +$3.29M 0.09% 205
2022
Q4 		$33.4M Sell
185,971
-45,474
-20% -$7.44M 0.11% 189
2022
Q3 		$27.4M Sell
231,445
-27,180
-11% -$4.12M 0.09% 222
2022
Q2 		$36.9M Buy
258,625
+1,438
+0.6% +$206K 0.1% 208
2022
Q1 		$44.3M Buy
257,187
+35,226
+16% +$5.93M 0.09% 216
2021
Q4 		$56.4M Sell
221,961
-8,921
-4% -$2.61M 0.11% 197
2021
Q3 		$88.9M Buy
230,882
+71,516
+45% +$26.4M 0.18% 120
2021
Q2 		$37.4M Buy
159,366
+16,571
+12% +$2.96M 0.08% 289
2021
Q1 		$18.7M Sell
142,795
-4,023
-3% -$583K 0.04% 462
2020
Q4 		$15.3M Sell
146,818
-11,670
-7% -$1.18M 0.04% 507
2020
Q3 		$11.2M Buy
158,488
+16,090
+11% +$1.12M 0.03% 592
2020
Q2 		$9.14M Buy
142,398
+112,110
+370% +$6.14M 0.03% 635
2020
Q1 		$907K Buy
30,288
+870
+3% +$20K ﹤0.01% 1223
2019
Q4 		$575K Buy
29,418
+500
+2% +$8.87K ﹤0.01% 1395
2019
Q3 		$460K Buy
+28,918
New +$427K ﹤0.01% 1356

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

State of Wisconsin Investment Board's MRNA Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its Moderna (MRNA) stake by 8.6% in Q2 2026, selling an estimated $1.01M and leaving 207,705 shares worth $14.5M. The position accounts for 0.03% of the portfolio, ranked #497.

State of Wisconsin Investment Board first reported a position in MRNA in Q3 2019 and has held it in 28 quarters since. The position peaked at $88.9M in Q3 2021. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • State of Wisconsin Investment Board held 207,705 shares of Moderna worth $14.5M as of Q2 2026.
  • State of Wisconsin Investment Board sold 19,457 Moderna shares in Q2 2026, an estimated $1.01M.
  • Moderna made up 0.03% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #497 holding.
  • State of Wisconsin Investment Board first reported a position in Moderna in Q3 2019 and has held it in 28 quarters since.
  • State of Wisconsin Investment Board's Moderna position peaked at $88.9M in Q3 2021.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.